These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 32929364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.
    Miles WO, Lembo A, Volorio A, Brachtel E, Tian B, Sgroi D, Provero P, Dyson N.
    Cancer Res; 2016 Dec 15; 76(24):7231-7241. PubMed ID: 27758885
    [Abstract] [Full Text] [Related]

  • 5. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA.
    Oncotarget; 2016 Apr 12; 7(15):19519-30. PubMed ID: 26799586
    [Abstract] [Full Text] [Related]

  • 6. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY, Zheng XH, Deng AP, Wang Y, Liu J, Zhou Q, Cheng GY, Jiang Q.
    Eur Rev Med Pharmacol Sci; 2019 Dec 12; 23(23):10433-10442. PubMed ID: 31841197
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
    Xiang Y, Ye Y, Lou Y, Yang Y, Cai C, Zhang Z, Mills T, Chen NY, Kim Y, Muge Ozguc F, Diao L, Karmouty-Quintana H, Xia Y, Kellems RE, Chen Z, Blackburn MR, Yoo SH, Shyu AB, Mills GB, Han L.
    J Natl Cancer Inst; 2018 Apr 01; 110(4):379-389. PubMed ID: 29106591
    [Abstract] [Full Text] [Related]

  • 8. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
    Mou E, Wang H.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31399501
    [Abstract] [Full Text] [Related]

  • 9. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 30; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 10. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y, Teng L, Fu S, Wang G, Li Z, Ding C, Wang H, Bi L.
    BMC Cancer; 2021 May 31; 21(1):644. PubMed ID: 34053447
    [Abstract] [Full Text] [Related]

  • 11. Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1.
    Hu Z, Li M, Chen Y, Chen L, Han Y, Chen C, Lu X, You N, Lou Y, Huang Y, Huo Z, Liu C, Liang C, Liu S, Deng K, Chen L, Chen S, Wan G, Wu X, Fu Y, Xu A.
    Sci China Life Sci; 2024 Jun 31; 67(6):1212-1225. PubMed ID: 38811444
    [Abstract] [Full Text] [Related]

  • 12. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J, Weng T, Ko J, Chen NY, Xiang Y, Volcik K, Han L, Blackburn MR, Lu X.
    Biochem Biophys Res Commun; 2018 Sep 05; 503(2):856-862. PubMed ID: 29928883
    [Abstract] [Full Text] [Related]

  • 13. 3'UTR shortening and EGF signaling: implications for breast cancer.
    Akman HB, Oyken M, Tuncer T, Can T, Erson-Bensan AE.
    Hum Mol Genet; 2015 Dec 15; 24(24):6910-20. PubMed ID: 26395459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M, Li A, Zhou S, Lv H, Yang W.
    J Hematol Oncol; 2019 Feb 08; 12(1):14. PubMed ID: 30736840
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
    Sheng J, Xue X, Jiang K.
    Curr Mol Med; 2019 Feb 08; 19(2):147-155. PubMed ID: 30854965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.